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Biofabrication of human articular cartilage: a path towards the development of a 
clinical treatment 
Abstract 
Cartilage injuries cause pain and loss of function, and if severe may result in osteoarthritis (OA). 3D 
bioprinting is now a tangible option for the delivery of bioscaffolds capable of regenerating the deficient 
cartilage tissue. Our team has developed a handheld device, the Biopen, to allow in situ additive 
manufacturing during surgery. Given its ability to extrude in a core/shell manner, the Biopen can preserve 
cell viability during the biofabrication process, and it is currently the only biofabrication tool tested as a 
surgical instrument in a sheep model using homologous stem cells. As a necessary step toward the 
development of a clinically relevant protocol, we aimed to demonstrate that our handheld extrusion device 
can successfully be used for the biofabrication of human cartilage. Therefore, this study is a required step 
for the development of a surgical treatment in human patients. In this work we specifically used human 
adipose derived mesenchymal stem cells (hADSCs), harvested from the infrapatellar fat pad of donor 
patients affected by OA, to also prove that they can be utilized as the source of cells for the future clinical 
application. With the Biopen, we generated bioscaffolds made of hADSCs laden in gelatin methacrylate, 
hyaluronic acid methacrylate and cultured in the presence of chondrogenic stimuli for eight weeks in 
vitro. A comprehensive characterisation including gene and protein expression analyses, 
immunohistology, confocal microscopy, second harmonic generation, light sheet imaging, atomic force 
mycroscopy and mechanical unconfined compression demonstrated that our strategy resulted in human 
hyaline-like cartilage formation. Our in situ biofabrication approach represents an innovation with 
important implications for customizing cartilage repair in patients with cartilage injuries and OA. 
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Cartilage injuries cause pain and loss of function, and if severe may result in osteoarthritis.  
3D bioprinting is now a tangible option for the delivery of bioscaffolds capable of regenerating 
the deficient cartilage tissue. Our team has developed a handheld device, the Biopen, to allow 
in situ additive manufacturing during surgery. Given its ability to extrude in a core/shell 
manner, the Biopen can preserve cell viability during the biofabrication process, and it is 
currently the only biofabrication tool tested as a surgical instrument in a sheep model using 
homologous stem cells.  
As a necessary step toward the development of a clinically relevant protocol, we aimed to 
demonstrate that our handheld extrusion device can successfully be used for the biofabrication 
of human cartilage. Therefore this study is a required step for the development of a surgical 
treatment in human patients. 
In this work we specifically used human derived mesenchymal stem cells (hADSCs), harvested 
from the Infra-Patellar Fat Pad of donor patients affected by Osteoarthritis, to also prove that 
they can be utilized as the source of cells for the future clinical application.  
With the Biopen, we generated bioscaffolds made of hADSCs laden in Gelatin Methacrylate 
(GelMa), hyaluronic acid methacrylate (HAMa) and cultured in the presence of chondrogenic 
stimuli for eight weeks in vitro.     
A comprehensive characterisation including gene and protein expression analyses, 
immunohistology, confocal microscopy, second harmonic generation, light sheet imaging, and 
mechanical unconfined compression demonstrated that our strategy resulted in human hyaline-
like cartilage formation.  
Our in situ biofabrication approach represents an innovation with important implications for 
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Hyaline cartilage tissue regeneration remains a challenge for musculoskeletal tissue 
engineering. As a highly specialised tissue, it is characterised by low cell numbers, an avascular 
aneural and aliphatic environment, a distinct three dimensional collagen fibre structure, 
aggregated proteoglycans and matrix organisation [1]. All these characteristics confer specific 
mechanical properties [2] [3], and make articular cartilage a challenging tissue to regenerate in 
vitro and in vivo. Promising surgical treatments include Autologous Chondrocyte implantation 
(ACI) and Matrix-induced Autologous Chondrocyte implantation (MACI) that some have 
reported to be superior to self–repair inducing techniques such as microfractures [4] [5].  
Nevertheless, MACI and ACI are multistage, complex procedures. These techniques require a 
double operation: the surgical excision of native cartilage tissue and the expansion of adult 
chondrocytes in vitro before implantation [5]. Previous studies have reported that 68% of 
patients treated with the clinical product approved by the US Food and Drug Administration 
(Carticel ®) had graft failure, delamination or tissue hypertrophy [6]. The major drawbacks 
include the need for two operations, and that adult chondrocytes have the propensity to undergo 
de-differentiation [7], thus losing the capability to produce hyaline cartilage extracellular 
matrix and giving rise to reparative tissue that lacks durability [8] [9]. The lack of durability of 
repaired cartilage leads to the development of osteoarthritis (OA) [10][11], which severely 
limits the quality of life of affected individuals and represents one of the greatest contributors 
to healthcare expenditure worldwide [12].  
Regenerating healthy and long lasting articular hyaline-like cartilage is therefore considered a 
key aim in musculoskeletal tissue engineering [13]. In this regard, mesenchymal stem cells 
(MSCs) have been heralded as an appropriate candidate for cartilage repair owing to several 
specific characteristics such as inherent chondrogenic property, ready availability, and cell 
homing potential [14]. Despite these qualities, their use is still limited, with only 16% of 
reported cell therapy procedures for cartilage repair registered at https://www.clinicaltrial.gov/ 
using MSCs [15].  
3D bioprinting has added considerably to standard tissue engineering techniques, thanks to its 
precision and control [16]. This promising technique can be applied to regenerate biological 
tissues such as bone and cartilage [17][18]. A key challenge is now to bring cumbersome 
bench-based technology to the operating room for real-time application.  
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3D printing of scaffolds for chondral and osteochondral repair has been tried, using a 
mosaicplasty-type technique, based on the implantation of scaffolds in defects that are pre-
made in the laboratory before surgery [19][20][21][22]. 3D printing has the advantage of being 
coupled with the use of “custom-designed” implants modelled on pre-operative MRI and/or 
CT scans. For “custom designed” bench-based 3D printing techniques a highly detailed pre-
operative image of the cartilage defect needs to be obtained, so that the 3D printer can create 
the desired bioscaffold to match the specific defect. Despite these strategies, however, a 
mismatch between the bioscaffold and the host defect will likely remain because surgical 
debridement before implantation alters the anatomy previously imaged, and even the most 
advanced imaging techniques still fail to identify small gaps and defects. These issues 
inevitably impede perfectly matching off-the-shelf and custom-designed prefabricated 
bioscaffolds. The mechanical mismatch between implanted scaffolds and surrounding tissues 
may inhibit cartilage regeneration at defect sites leading to implant failure [23]. In their 
literature review, Mollon et al. summarized the limitations associated with current cartilage 
repair techniques and noted that graft-site mismatch and size-depth mismatch were the most 
frequent [24]. 
To tackle this challenge, as an alternative to computer aided 3D printing, we propose in situ 
additive manufacturing. The advantages of in situ biofabrication for cartilage regeneration 
include the possibility of perfectly match the defect geometry without specific preliminary 
image analysis, shaping the bioscaffold within the defect and achieving the best possible 
contact between the bioscaffold and the host tissue. In situ bioprinting has been proposed as a 
valid option to deliver at the time and point of need a bioscaffold capable of regenerating 
deficient tissue [25][26] and to limit the graft-site mismatch.  Also a number of ex vivo 
approaches have been proposed [27][28] to test the effective use of cell based therapies within 
a defined defect, but to our knowledge our extrusion device, the Biopen [29], remains the only 
hydrogel injection system that has been tested as a surgical instrument in a large animal model 
of cartilage regeneration [30]. The Biopen is an advanced handheld co-axial extrusion device 
that allows the deposition of cells embedded in a hydrogel material in the surgical setting. 
Through this device, stem cell laden hydrogel scaffolds can be extruded in a co-axial core/shell 
distribution, which favourably affects cell survival while maintaining adequate mechanical 
properties for cartilage tissue engineering purposes. This result is achieved thanks to the 
segregation of the cells in the core away from the photocrosslinking reaction confined to the 




Our in vivo study was performed using allogenic ovine adipose derived stem cells [30]. To 
progress towards translating our biofabrication tool into clinical practice, we aim to 
demonstrate that the advantages of the Biopen are pivotal for the biofabrication of the human 
cartilage. Therefore, this study is a required step in the development of a clinically relevant 
protocol for the application of this biofabrication process in the clinical practice (Figure 1). 
 
Figure 1. The path towards the development of a clinical treatment. The flow chart lists steps achieved (in 
green) and the steps ahead (in red). The current study is indicated as the Neocartilage Biofabrication step and 
represents the last in vitro analysis before the ex vivo and in vivo animal studies.  
 
In our study we specifically used human derived mesenchymal stem cells (hADSCs), harvested 
from the Infra-Patellar Fat Pad of donor patients affected by Osteoarthritis, envisioning them 
as the source of cells for the future clinical application. We screened three different hADSCs 
from three different patients to take in account also the inter-patient variability. Thus, for each 
cell line we evaluated stemness and differentiation potential. 
We used the Biopen to generate bioscaffolds in which hADSCs were laden in  Gelatin 
Methacrylate (GelMa) and hyaluronic acid methacrylate (HAMa) [29]. We cultured the 
bioscaffolds in chondrogenic media for eight weeks and we analysed their ability to form 
hyaline-like cartilage using molecular, imaging and mechanical analyses.  
To our knowledge, we are the first to describe the capacity of a surgical device to biofabricate 
in situ a regenerative stem cells niche. The impact of this technology has the potential to change 







2. Materials and methods 
2.1. Experimental design   
Human stem cells were harvested and isolated from the infrapatellar fat pad of patients 
undergoing total joint knee replacement. A comprehensive profile analysis of 
immunophenotypic characterization and evaluation of the differentiation potential was used to 
assess the stemness of three different cell lines from three different donors to be used for the 
bioprinting step. We then utilized the Biopen to biofabricate the scaffolds. To control the size 
and shape of our samples, we used PDMS cylindrical moulds of 1 cm diameter and 1 mm 
thickness with a total volume of approximately 80 l, so < 2 cm2, which is considered a critical 
size defect in human cartilage injuries [32]. the limitations of the PDMS material, which is 
more compliant and flexible than native cartilage, this bioprinting approach guarantees 
reproducibility of structural organization and cell number, with suitable geometry for 
mechanical testing, and was used for the entire set of experiments. We then extruded multiple 
layers until the mould was filled to recreate a 3D structure.  
After the photopolymerization reaction, we moved the samples to static culture conditions and 
we cultivated the samples for 8 weeks in control or chondrogenic differentiation media. The 
samples, three biological replicates [n = 3] for each of the three patients derived cell lines, were 
collected and analysed every 4 weeks for a total of three time points. We then analysed the 
capability of our biomanufactoring strategy to produce hyaline-like neocartilage. The cellular 
response to the chondrogenic stimuli was determined by gene and protein expression analysis. 
The building of new tissue was defined by protein localization and organization of the main 
components of hyaline cartilage. The function of the neocartilage was then related to the 




       
 
Figure 2.  Graphical representation of the experimental plan and the corresponding time line. Three different cell 
lines isolated from three patients were analysed in triplicate. 
 
2.2. Synthesis of GelMa/HAMa 
Gelatin-methacryloyl/hyaluronic acid methacryloyl (GelMa/HAMa) was synthesized as 
previously described [31]. Briefly, the materials were dissolved to a final concentration of 100 
mg ml−1 GelMa and 20 mg ml−1 HAMa (10% GelMa-2% HAMa) in sterile PBS (Sigma-














2.3. Stem cells preparation 
2.3.1. Stem cells isolation 
Human Adipose Derived Stem cells (hADSCs) were isolated from human InfraPatellar Fat Pad 
(IPFP) obtained intraoperatively from total knee arthroplasty with informed consent and 
approval. Patients with mild/severe OA were recruited. A total of three patients were selected 
for IPFP harvest. Use of all human samples and procedures in this study was approved by the 
Human Research Ethics Committee Research Governance Unit of St. Vincent’s Hospital, 
Melbourne, Australia [HREC/16/SVHM/186] and all the experiments were performed in 
accordance with relevant guidelines and regulations.   
hADSCs were isolated and expanded as previously described [33]. Briefly, the fat was diced 
using a sterile scalpel and digested with 0.1% collagenase type I (Worthington Biochemical) 
for 3 h at 37 °C under constant agitation, filtered through 100 m cell strainer nylon (BD 
Falcon) and centrifuged at 400g at room temperature for 5 min to separate the stromal fraction 
from the floating adipocytes. The supernatant was discarded and the cell pellet was 
resuspended in Red Cell Lysis Buffer (160 mM NH4Cl; Sigma-Aldrich) and incubated at room 
temperature for 10 min. The lysate was centrifuged at 400 g at room temperature for 5 min and 
filtered through a 40 m nylon cell strainer (BD Falcon). The isolated cells were then plated in 
monolayer culture and allowed to adhere for 48 h in culture media containing low glucose 
DMEM (St.Louis, LA, USA) supplemented with 10% FBS (GIBCO, Thermo Fisher Scientific 
Inc., Waltham, MA, USA), 100 U ml-1 Penicillin and 100 g ml-1 Streptomycin solution 
(GIBCO), 2mM L-Glutamine (GIBCO), and 15 mM HEPES (GIBCO), 20 ng ml-1 epidermal 
growth factor (EGF) and 1 ng ml-1 fibroblast growth factor (FGF) (R&D Systems Inc., 
Minneapolis, MN, USA). Non-adherent cells were then removed and the medium was replaced 
with fresh medium. Cells were further cultivated and expanded for cell surface epitope 











2.3.2. Stemness immunophenotypic characterization and differentiation potential 
Immunophenotypic characterization of hADSCs was performed by fluorescence flow 
cytometry analysis of cell-surface markers at passage 2 (P2). Cells were labelled with 
monoclonal antibodies against CD14, CD31, CD34, CD45, CD73, CD90, CD106, CD146 - 
FITC conjugates and  CD105, HLA-DR, CD29, CD44, CD49e - APC conjugated (Affimetrix 
eBiosceince, ThermoFisher Scientific). Control samples were labelled with isotype-matched 
control antibodies IgG1K-FITC and IgG1K-APC (Affimetrix eBiosceince). In brief, cells were 
trypsinized and aliquoted at a concentration of 2.5 × 105 cells ml-1, fixed in 0.5% 
paraformaldehyde for 30 min at 4 °C, and washed once in PBS 1X. Next, samples were 
incubated with either conjugated specific antibodies or isotype-matched control at the 
manufacturer’s recommended concentrations, diluted in PBS 1X supplemented with 5 % FBS 
(FACS buffer). Labelled cells were washed twice, suspended in FACS buffer, and analysed 
using a FC500 flow cytometer (Beckman Coulter).  
Chondrogenic differentiation was induced using the micromass pellet culture technique as 
described previously [34], [35].  Briefly, 2.5 × 105 confluent P03 cells ml-1 were placed in 1.5 
mL screw cap tubes (Sarstedt), centrifuged at 400g for 5 min to form the pellets and cultivated 
with either non chondrogenic control medium consisting of DMEM high-glucose (Lonza), 100 
U ml−1 penicillin and 100 μg ml−1 of streptomycin (Gibco), 1X Glutamax (Gibco), and 15 mM 
HEPES (Gibco), or chondrogenic medium consisting of DMEM high-glucose (Lonza), 100 U 
ml−1 penicillin and 100 μg ml−1 of streptomycin (Gibco), 1X Glutamax (Gibco), and 15 mM 
HEPES (Gibco), 1% insulin–transferring–selenium (Sigma-Aldrich), 100 nM dexamethasone 
(Sigma-Aldrich), 50 mg/mL ascorbate-2-phosphate (Sigma-Aldrich), 10 ng/mL TGFb3 
(Prepotech), and 10 ng/mL BMP6 (R&D Systems).  
Osteogenic differentiation was induced at P03 by seeding hADSCs in α-MEM supplemented 
with 2% FBS in six-well plates at 5 × 105 cells per well. The next day, an osteogenic 
inducing cocktail composed of 10 mM β-glycerophosphate (Sigma, St. Louis, MO, USA), 50 
μg/mL ascorbic acid (Sigma) and 100 nM dexamethasone (Sigma) was added. 
As a negative control, cells seeded under the same conditions were maintained in a non-
inducing medium.  
The medium was changed every 2 days and three biological replicates [n = 3] per time point 
and type of analysis at 0 and 4 weeks of culture/group were processed. Immuno/histochemistry 
and Reverse transcription-Quantitative Polymerase Chain Reaction (RT-qPCR) were 




2.4. Generation of Bioscaffolds with the Biopen  
Co-axial extrusion was performed using the handheld extrusion system (Biopen) using the 
same parameters previously described [31]. Briefly, both Biopen chambers were loaded with 
10% GelMa-2% HAMa. hADSCs were mixed to a final concentration of 10 × 106 cells ml-1 
and carefully loaded in the core chamber, while for the shell chamber 0.1% w/v Lithium-
acylphosphinate (LAP) (Tokyo Chemical Industry Co., Tokyo, Japan) was mixed through the 
GelMa/HAMa. The temperature of the solutions was stabilized at 37 °C prior to preparation. 
Samples were Biopen extruded into PDMS moulds to produce disc-like shaped bioscaffolds 
(height = 1 mm, diameter = 10 mm). Immediately after extrusion the samples were then UV 
irradiated at room temperature for 10 seconds, using a 365 nm UV source (Omnicure LX400+, 
Lumen DynamixLDGI) fitted with a 12 mm lens (25 mm focal distance) with a light intensity 
of 700 mW/cm2.  
 
2.5. In vitro culture of bioscaffolds 
The generated bioscaffolds were then transferred to a 24 well plastic plate, washed three times 
in PBS 1X and 1mL of chondrogenic or control medium was added to each well. Pictures of 
the entire samples were taken with a 7 megapixel camera. 
Chondrogenic differentiation was induced as previously described for the pelleted culture cells 
(paragraph 2.3.2.) and three biological replicates [n = 3] per time point and type of analysis at 
0, 4 and 8 weeks of culture/group (differentiated vs undifferentiated) were processed.  
 
2.6. Histological analysis 
For chondrogenic analysis, pelleted cells and Biopen manufactured samples were fixed in 1% 
paraformaldehyde (Santa Cruz Biotechnology, Dallas, TX, USA) for 4 h at room temperature, 
embedded in O.C.T. TM Compound (Tissue-Tek, Sakura, Leiden, Netherlands) and flash 
frozen in liquid nitrogen. Cryosections of 10 m thickness were mounted onto glass slides and 
stained with Safranin O (Sigma-Aldrich) for 10 min, dipped in 95% and 100% EtOH, cleared 
three times for 1 min each in Xylene (Chem-Supply, GILLMAN, SA, Australia) and then 
mounted in Pertex medium (Grale HDS, Ringwood, VIC, Australia).  
For osteogenic differentiation analysis, cultured cells were stained with Alizarin Red-S (AR-
S) (Sigma) to reveal the deposition of a calcium-rich mineralized matrix [36]. Quantification 
of Alizarin was performed by Cetylpyridinium chloride extraction and spectrophotometric 
measurement at 562nm. 
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Samples were imaged using an epifluorescent inverted NikonTiE microscope equipped with a 
DS-Ri2 and NIS-Elements software using a PlanFluor ELWD 20X DIC L NA 0.45 objective. 
Figure panels were assembled using Photoshop software (Adobe). 
 
2.7. RNA extraction and RT-qPCR 
Total RNA from hADSCs, cultured, pelleted or bioprinted, were harvested at indicated time 
points using Tri Reagent (Ambion, Austin, TX, USA) according to the manufacturer’s 
protocol. DNA contamination were digested by DNAse I (Sigma). Reverse transcription (RT) 
was performed using Omniscript reverse transcription kit (Quiagen) following the 
manufacturer’s protocol. The relative amounts of COl2A1, COL1A2, ACAN, SOX9, RUNX2, 
COL10A1, RPL13 and GAPDH RNAs were evaluated with TaqMan Gene expression assay 
(Applied Biosystems, Foster City, CA, USA) using the following probes:  
SOX9 (Hs00165814_m1), ACAN (Hs00153936_m1), COL2A1 (Hs00264051_m1) and 
COL1A2 (Hs00164004_m1) RUNX2 (Hs01047973_m1), COL10A1 (Hs00166657_m1) as 
target genes; GAPDH (Hs02786624_g1) and RPL13a (Hs04194366_g1) as housekeeping 
genes. qPCR was performed on a QuantStudio 6 Flex Real-Time PCR System (Thermo Fisher 
Scientific) and relative quantification was calculated with the 2E−ΔΔCT method. The mean 
ΔCT value of the control sample was used in each experiment to calculate the ΔΔCT value of 
sample replicates by using an average of two different housekeeping genes (RPL13 and 
GAPDH). Statistical analysis on the data obtained was performed by using unpaired T-Test on 
three experimental replicates by considering significative data with a P value < 0.05. Graphs 
were designed using Prism 5 software (GraphPad) and figure panels were assembled using 
Photoshop software (Adobe). 
 
2.8. Protein extraction and Western blot analysis  
Biopen printed samples were collected at the indicated time points, washed three times for 5 
min each with PBS 1X on a rotating platform at room temperature, transferred in a 1.5mL 
Eppendorf tube, then flash frozen in liquid Nitrogen and stored at -80°C. Whole protein content 
was extracted on ice by manually break with a pestle in 30 l/samples of 2X RIPA buffer (750 
mM NaCl, 5% Triton X100; 2.5% Sodium Deoxycolate; 10% SDS; 1M Tris, pH 8) with the 
addition of protease inhibitor cocktail (Roche). Samples were incubated on ice for 20 min and 
cleared by centrifugation at 14000 rcf for 20 min at 4 °C. The supernatant was recovered and 
carefully transferred in a new labelled tubes. Protein extract was quantified 
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spectrophotometrically with the BCA Protein Assay (Thermo scientific). The same amount of 
proteins was separated in loading buffer (Thermo scientific) in 4%-12% Bolt Bis-Tris precast 
Gel (Thermo scientific) in MES buffer (Life technologies) for 30 min at constant voltage (180 
V). Spectra Multicolor Broad range protein ladder (Thermo scientific) was used as a protein 
standard. After the electrophoretic separation, proteins were blotted to PVDF membrane with 
iBlot 2 system (Life Technologies), following manufacturer’s instructions. Protein transfer was 
assessed by Ponceau (sigma) staining. The membrane was blocked against non specific 
bindings with 5% non-fat dry milk (Coles) in TBS-T (50 mM Tris-Cl, pH 7.6; 150 mM NaCl; 
0.1% Tween 20) for 1 h at room temperature. After three washes in TBS-T for 10 min, the 
membrane was incubated overnight at 4 °C with rabbit monoclonal anti human SOX 9 antibody 
(#EPR14335, Abcam) or mouse monoclonal anti human β-Actin (#A5316, Sigma Aldrich) in 
3.5% Bovine Serum Albumin in TBS-T. After three washes in TBS-T for 10 min, the 
membrane was incubated for 1 h at room temperature with anti-rabbit secondary antibody HRP 
conjugated (Dako). Finally, after three washes in TBS-T for 10 min, the signal was revealed 
with Western Blot Lightning ECL pro kit (PerkinElmer) and imaged with Chemidoc MP 
imaging system (Biorad). Figure panels were assembled using Photoshop software (Adobe). 
 
2.9. Immunostaining analyses and fluorescent imaging  
For fluorescence analysis, 10 m thickness slices from both pelleted cell culture and Biopen 
printed, were washed three times in PBS1X and permeabilized for 15 min in PBS 1X-0.1% 
TritonX-100 (PBT). Antigen retrieval was performed only for hydrogel printed samples by 
adding 1mg/mL Hyaluronidase (SIGMA, #H6254) diluted in PBS 1X and incubating 30 min 
at room temperature. After three washes 5 min each in PBS 1X, samples were dropped in 
Blocking solution (10% goat serum diluted in PBT) for 60 min at room temperature and then 
incubated overnight at 4 °C with mouse anti-human Collagen II (#II6B3, DSHB), goat anti-
human Collagen I (#sc8784, Santa Cruz), mouse anti-human Proteoglycan (#MAB2015, 
MerckMillipore) and mouse anti-human Collagen X (#ab49945, Abcam), diluted 1:250 in 
blocking solution. The day after, samples were washed three times for 10 min each and 
secondary antibodies both diluted 1:100 in blocking solution were added, respectively anti-
mouse IgG Alexa Fluor-647 (#715-605-151, Jackson Immuno Research) and anti-goat IgG 
Alexa Fluor-546 (#A11056, Thermo Fisher Scientific Inc.), and incubated for 2 h at room 
temperature. After three washes 5 min each in PBS 1X, actin was labelled with Texas Red-X 
Phalloidin (#T7471, Thermo Fisher Scientific Inc.) 1:100 diluted in PBS 1X for 60 min at room 
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temperature and nuclei were stained by incubation with 5 µg/mL DAPI (Thermo Fisher 
Scientific Inc.) diluted in PBS 1X for extra 60 min at room temperature.  
The sections were washed three times 5 min each in PBS 1X, mounted with Fluoromount-G 
(Southern Biotech, Birmingham, AL, USA) onto glass slides. Pellet sections were imaged 
using an epifluorescent inverted NikonTiE microscope equipped with a DS-Ri2 and NIS-
Elements software using a Plan Fluor ELWD 20X DIC L NA 0.45 objective. Biopen printed 
samples were imaged with NikonA1R confocal microscope using a Nikon Plan  
 VC 20x DIC N2 N.A. 0.75 objective lens and “Scan large image” from NIS-Elements software 
tool was used to image a larger field of view. 
Digital images were processed using NIS-Elements software (Nikon, Amsterdam, Netherlands) 
and Photoshop software (Adobe) was used to assemble the figure panels. All the images shown 
in this study are representative of at least three independent experiments.  
The fluorescence measurement analysis of Figure 6C was performed with the “Annotations and 
Measurements” feature of NIS-Element software. 
The intensity of the Collagen type II corresponding channel was calculated by normalizing the signal 
for the identified positive area. The percentage of the positive area was calculated in relation to the total 
area of the field of view, which was the same for all the images acquired and that corresponded to 3mm2.    
Those analyses were performed on three different fields of view for each sample.  
 
2.10. Second Harmonic generation Microscopy 
Regions of interest images (5 mm x 5 mm) were acquired on a fully automated, programmable, 
multiphoton imaging platform (Genesis® 200, HistoIndex Pte Ltd, Singapore) following 
sectioning and mounting of 10 μm-thick cryosections washed out from OCT. Laser excitation 
occurred at 780 nm. Forward-scatter two-photon excitation (TPE) and second harmonic 
generation (SHG) signals were detected using dedicated photomultiplier tubes for each 
channel. Magnification was set to 20x. TPE sensitivity was set to 0.7, and SHG sensitivity to 
0.6. A bandpass filter with center wavelength at 550 nm and bandwidth of 88 nm was set in 
front of the TPE photodetector. Laser baseline power was set at 0.5, and then stepped down by 
60% using a set of 2 optical attenuators (0.1OD, 0.3OD - “Low” laser power configuration). 
No change was made to the polarization of the laser source, and no polarization was used on 






2.11. Whole sample staining and light sheet imaging  
Entire bioscaffolds were transferred to clean 12 well plates, washed 3 times 10 min each in 
PBS 1X and fixed in Paraformaldehyde 4% for 30 min. After washing three times for 10 min 
each in PBS 1X, samples were permeabilized in PBT (0.1% Triton in PBS 1X) for 60 min. 
Actin was labeled with Texas Red-X phalloidin (#T7471, Thermo Fisher Scientific Inc.) 1:100 
diluted in PBS for 2 h.  The excess of phalloidin was removed by washing 3 times 10 min each 
in PBS 1X. Nuclei were stained by incubation with 5 µg/mL DAPI (Thermo Fisher Scientific 
Inc.) diluted in PBS 1X for extra 60 min. Samples were finally washed 3 times 10 min each in 
PBS1X and left at 4 ºC until imaging.  
For light sheet imaging, samples were hooked and loaded in a glass capillary (size 2 black, 
inner diameter of capillary ~1mm, #701932, BRAND GmbH). The glass capillary was 
mounted in the chamber, which was filled PBS 1X. A Lightsheet Z.1 microscope (Carl Zeiss 
Microscopy GmbH, Jena, Germany), with 20×/1.0 NA water dipping detection objective and 
two-sided 10×/0.2 illumination optics, equipped with two PCO EDGE 4.2 cameras (sCMOS 
sensor, square pixels of 6.5×6.5 μm side length, 2048×2048 pixel resolution, 3-channel images, 
16 bit dynamic range) (PCO AG, Kelheim, Germany) were used for light sheet imaging. For 
DAPI and Phalloidin-actin 1.5%-405 nm and 8.6%-561 nm laser powers respectively and 50 
ms exposure time were used. Pivot scanning mode (Carl Zeiss) was used to deliver 
homogeneous illumination and prevent shadows along the illumination axis. For all 3D 
datasets, a z-interval of 2 μm with a zoom of 0.50 was used. The volumetric images were 
1131×1131×1000 μm (1920×1920×500 pixels) in size, with 0.589×0.589×2.000 μm3 
resolution. To counteract the degradation of the light sheet by the high amount of scattering, 
the specimen was sequentially illuminated through each of the two opposing illumination 
objectives, generating pairs of illuminated single-side images, and then combined into fused 
single illumination optical sections with a considerably improved penetration depth. All 
acquired LSFM raw data were processed using ZEN 2011 imaging software (Carl Zeiss, 
Germany). Optical sections were merged and combined into a single three-dimensional data 









2.12. Compression testing  
The tests were performed at room temperature using a TA Electroforce 5500 mechanical 
loading device (TA Instruments, New Castle, USA) fitted with a calibrated 22 N load cell. The 
contact point between the two plates was recorded. Then, the sample was placed between two 
4.2 cm diameter compression plates, in an unconfined setting as previously described [37]. The 
displacement of the upper plate was controlled by a ramp function, at a rate of 0.01 mm/s, until 
a total displacement of 25% of the sample height. The contact area of the sample with the plate 
was measured by microscopy imaging before the test. Additionally, the point of inflexion of 
the load versus time curve showed the contact point between the sample surface and the 
compression plate to give the sample height. Load and displacement measurements were 
converted into stress (σ) and strain (ε) data using the sample surface area and height. The 
compressive modulus was then computed using stress data between 10 and 15% strain as 
follows: Ec = (σ15−σ10) (ε15 − ε10)⁄ .  
Three biological replicates [n = 3] for each of the three patients per time point and type of 
analysis at 0, 4 and 8 weeks of culture/group (differentiated vs undifferentiated) were 
processed. Data Graphs were designed using Prism 5 software (GraphPad). 
 
2.13. Atomic Force Microscopy 
AFM nanoindentation was performed on an MFP-3D (Asylum Research) using a contact 
mode MLCT probe (Bruker Nano Inc.) with a stiffness calibrated as 0.135 N/m. Force curves 
were performed to an indentation force of 5 nN at an approach rate of 2 m/s. The Young’s 
Modulus was obtained using the Hertz indentation model approximating the tip-shape as a 
19.2 cone. Bioprinted hydrogel samples were submerged in PBS 1X during measurement. 
For each bioprinted sample, 16 indentations across 5 regions were performed in a 
standardized fashion, making 80 force curves per sample. Three samples for each of the 
control week 8 and chondrogenic week 8 groups were measured. The same AFM probe was 
used for all measurements. 
 
2.14. Statistical Analysis 
All statistical analyses were performed using Prism 5 (GraphPad) software with a statistical 
significance level of 0.05. Differences between the experimental groups were determined using 
unpaired t test or one-way Anova tests with Dunnett’s corrections as indicated. In all graphs 




3.1. Comprehensive profile analysis of hADSCs identifies the infrapatellar fat pad as a 
source of stem cells for in situ biofabrication 
We isolated infra-patellar adipose derived stem cells (hADSCs) from three patients undergoing 
total joint knee replacement and characterized their stemness and differentiation potential. To 
account for any possible inter-patients variability, we decided to test our biofabrication strategy 
on different stem cells derived lines from patients’ donors.  
We first evaluated the cell morphology, plastic adherence after isolation, and the expression of 
typical stemness surface markers. The three lines displayed the typical spindle-shaped 
appearance at early passages and exhibited a smoothened morphology after long-term 
expansion, developing a larger and more granular cytoplasm (data not shown). Flow cytometry 
analysis documented that >90% of hADSCs expressed CD90, CD73, CD105 CD29, CD49. 
More than 90% of cells were also positive to the hyaluronan receptor CD44, which role is 
important in the early stages of cartilage development [38]. More than 60% of hADSCs were 
positive for HLA-DR, whereas the expression of the hematopoietic markers CD14, CD31, 
CD34, CD45 was <3%. The markers CD106 and CD146 were expressed in less than 10% of 
hADSCs as previously shown [39]. No significant difference among the three patients was 
scored, confirming that with our established laboratory procedures we are able to isolate and 
expand a homogenous stem cell population despite the donor tissue variability (Supp. figure 
1). The chondrogenic potential was then tested by pellet culture in vitro during a period of 4 
weeks, and production of chondral extracellular matrix (ECM) was confirmed (Figure 3). 
The initial assessment of chondrogenesis was based on the size and appearance of the pellets. 
After their generation, pellets grew in size and displayed a consistent white opaque 
macroscopic appearance (Figure 3(A)). Safranin O staining showed accumulation of 
Glycosaminoglycans (GAGs) deposition (Figure 3(A)) and changes in cell morphology from 
round shapes at week 0 to elongated cells encapsulated by an abundant ECM in the entire pellet 
structure (Figure 3(A)). Gene expression data confirm the increase expression of Collagen type 
II (COL2A1) and type I (COL1A2), Aggrecan (ACAN) and Sox-9 (SOX9) markers during the 
differentiation process (Figure 3(B)). COL2A1 and ACAN were not detectable in both 2D and 
pellet cultured hADSCs at steady state, but were activated only during the chondrogenesis 
process as a consequence of SOX9 increased expression. Finally, the immunostaining analyses 
revealed an increased expression of both Collagen type II and I during time, with a much 
stronger intercellular accumulation of Col II (Figure 3(C)). As previously shown [34, 35], hADSCs 
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from fat pad display the tendency to express higher level of collagen type II RNA and protein respect 
to Collagen type I during in vitro chondrogenesis under stimulation of TGFBeta3 and BMP6.  
To confirm further the differentiation potential of the isolated populations, we also tested the 




Figure 3. Comprehensive profile analysis of Infrapatellar Fat Pad derived hADSCs. (A) Histological analysis 
on 10 m cryosections stained with Safranin O to detect accumulation of GAG in the ECM. In the bottom left, 
the insets show the brightfield images of the whole pellets. The small panel on the right upper corner at Week 4 
shows a higher magnification image of cells encapsulated and surrounded by the ECM. (B) The graphs represent 
the fold changes calculated with 2^C method of Collagen type II (COL2A1) and type I (COL1A2), Aggrecan 
(ACAN) and Sox-9 (SOX9) markers. Fold Changes were normalized for RPL13a and GAPDH. Error bars 
represents standard deviation between three biological replicates and significant activity was calculated with 
unpaired t-test. These analyses have been performed on the hADSCs lines derived from three different patients 
and statistical analyses were performed as described in Materials and Methods section. (C) Immunostaining 
analysis on 10µm cryosections from pellet at Week 0 and Week 4 of chondrogenesis, performed using antibodies 
against Collagen type II (Col II) and I (Col I) shown in green, and DAPI  shown in violet to detect cells nuclei. 
Note: the images in A and C are the most representative selected from the immunohistology performed on the 









3.2. Neocartilage generation in vitro 
3.2.1. GAG accumulation during chondrogenic differentiation of hADASCs in 
GelMa/HAMa bioscaffolds 
We used the Biopen to generate bioscaffolds in which hADSCs were laden in Gelatin 
Methacrylate (GelMa) and hyaluronic acid methacrylate (HAMa). Both Gelatin (denatured 
collagen) and hyaluronic acid retain relevant cell-binding sites, while the addition of 
methacrylate groups renders the material amenable to rapid crosslinking using light, creating 
a hydrogel structure which is stable at physiological temperatures and achieves mechanical 
properties approaching that of native hyaline cartilage. As described in our previous paper 
[31] the 10s crosslinking time at 700 mW/cm2 with a 365 nm UV light source do not cause 
proliferation inhibition to hADSCs in the same core/shell bioprinting conditions. 
We produced tridimensional structures of the size of a critical cartilage injury, where a  critical 
size implies a defect which will not heal spontaneously without any intervention [40][41]. 
The neocartilage development was first qualitatively evaluated via the appearance of the 
bioscaffolds. The macroscopic brightfield images showed a marked difference in the opacity 
of the printed samples (Figure 4(A)) with a consistent white opaque macroscopic appearance 
developing over time only in the chondrogenic stimulated samples and not in the control group 
(Figure 4(A)).  
The deposition of the ECM in the hydrogel matrix was then verified histologically, by staining 
the sections derived from the same samples with Safranin O, as a reporter of GAG content [42] 
(Figure 4(B)). In the acellular scaffold, Safranin O stains a non-homogenous material. On the 
other hand, in the cell-laden bioscaffolds, the stem cells occupied defined lacunae in the 
surrounding hydrogel and exhibited a round shaped morphology when maintained in a control 
non-chondrogenic media.    
Upon chondrogenesis, the bioscaffolds showed a progressive formation of a compact and 
homogeneous matrix at Week 4 and Week 8 that is positive to Safranin O, demonstrating the 
accumulation of GAG (Figure 4(B)). The cells appeared elongated throughout the GAG 
forming a continuous structure. This analysis indicated a cell response to chondrogenic stimuli 




Figure 4. Neocartilage building and evaluation of GAG accumulation in Biopen extruded bioscaffolds.  
(A) Photographs show bioscaffolds from the control and the chondrogenic groups at the indicated time points. 
The white boxes outline the areas imaged in the histological analysis shown in the corresponding panels below. 
(B) Histological analysis from the corresponding samples of 10 µm cryosections, stained with Safranin O dye. 
Images were acquired with a 20X objective lens. Note: the images in A and B are the most representative selected 
from the analyses performed on bioscaffold constituted by three hADSCs lines derived from three different 
patients.   
 
 
3.2.2. Gene expression analysis evidences chondrogenic differentiation of hADSCs in 
GelMa/HAMa bioscaffolds 
To elucidate the capability of hADSCs to undergo chondrogenesis in the bioscaffolds, we 
analysed the gene expression of chondrogenic markers over a period of 8 weeks by RT-qPCR 
and Western blot analyses.  
The three hADSCs lines showed a progressive increase of the master transcriptional regulator 
of the chondrogenic program SOX9 both at transcriptional and translational level [43] [44] 
(Figure 5(A, B)).  
The intracellular accumulation of SOX9 led in turn to a progressive activation of its target 
genes COL2A1 and ACAN (Figure 5(A)). The three hADSCs lines did not exert any basal 
expression of the ECM components before the induction of chondrogenesis, as also 
confirmed by electrophoretic analysis of PCR amplified cDNA (Figure 5(A), lower panels). 
ACAN and COL2A1 expression was detectable 4 weeks after the start of the chondrogenesis 
differentiation, exerting an average fold change of 20 and of 140 respectively during the 
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following 4 weeks. hADSCs already expressed COL1A2 before the chondrogenesis 
differentiation and its level increase during time. Nevertheless, COL1A2 showed only a 10 
fold increase from week 0, while Collagen type II, which was not detectable at week 0, increases 
up to 200 folds at week 8 compared to week 4. Thus, the ratio between COL2A1 and COL1A2 
indicated the generation of hyaline-like cartilage rather than fibrocartilage, as described in 
previous works [45] [46] and in agreement with pellet culture data (Figure 3).  
 
       
Figure 5. Cellular response to chondrogenic stimuli. (A) The graphs represent the fold changes calculated with 
the ^C method of Collagen type II (COL2A1) and type I (COL1A2), Aggrecan (ACAN) and Sox-9 (SOX9) 
markers. Fold Changes were normalized for RPL13a and GAPDH. Error bars represents standard deviation 
between three biological replicates and significativity was calculated with unpaired t-test. These analyses have 
been performed on lines derived from three different patients. The lower panels show the electrophoretic analysis 
of the amplified cDNA to underline the switch in COL2A1 and ACAN expression during chondrogenesis.  





3.2.3. Generation of hyaline-like cartilage 
To analyse the process of biofabrication of chondral tissue in our Biopen extruded samples, we 
cryosectioned the bioscaffolds at the indicated time points and performed histological analysis 
by immunostaining with antibodies against Collagen type II (Col II), Collagen type I (Col I) 
(Figure 6) and Proteoglycan (Supp. figure 3) . The data obtained matched the gene expression 
analysis: Col I was already expressed at the start of the chondrogenic differentiation, while Col 
II was detected after 4 weeks (Figure 6(A)).  
Despite the fact that the intensity of the Col I signal increased during chondrogenesis, the 
intercellular Col II deposition and accumulation in the hydrogel matrix dramatically differed 
from Col I, reaching a strong and uniform pattern at week 8 of chondrogenesis. The thickness 
of the Col II-rich stripe increased from an average length of 400 m at week 4 up to 800 m 
at week 8 (Figure 6(A)). Those data are consistent with RT-PCR expression analyses where 
we demonstrated that the ratio between Collagen II and I is in favor of Collagen type II higher 
expression. Those results correlates with the generation of hyaline-like neocartilage.  
To confirm these data we analysed the fluorescence intensity profile and the relative percentage 
of the area that was positive for Col II on three fields of view for each of the three patient 
derived cell lines (Figure 6(B)). The results showed a significant difference in the fluorescence 
intensity between the samples collected at the start of the chondrogenesis and the differentiated 
samples at week 4 and week 8 on an area of 3 mm2 for each field analysed. Moreover, the 
fluorescent area was 26% of the 3 mm2 area at week 4 with a significant increase up to 40% at 
week 8 (Figure 6(C)). The changes in cell morphology during differentiation represents an 
important feature to estimate the degree of chondrogenesis [47]. As detected by actin staining 
of cytoskeleton, hADSCs modified their morphology over time from round shape to a more 
elongated appearance (Figure 6(B)). Collagen type II was strongly concentrated along the cell’s 
membranes and in the extracellular matrix, while collagen type I remained confined in the 
intracellular area (Figure 6(B)). Moreover, Collagen type X, a marker of hypertrophic 
differentiation, resulted to be expressed after 4 weeks of chondrogenesis, also with an 
intracellular accumulation (Supp. figure 4).   
Conversely, in the control bioscaffolds, in absence of chondrogenic stimuli, the expression of 












Figure 6. Neocartilage building and accumulation of Collagen type II.  (A) Immunostaining analysis on 10 
µm cryosections from Biopen biofabricated samples at Week 0, Week 4 and Week8 of chondrogenesis, performed 
using antibodies against Collagen type II (Col II, in green), Collagen Type I (Col I, in cyan) and counterstained 
with cell marker nuclei DAPI (in grey) and Texas Red-X phalloidin Actin (in red) to detect cell morphology. The 
superimposed signals are shown in the last columns (merge + Nuclei Actin). The images are orientated with the 
surface of the samples toward the top. (B) The panels show higher magnification of sections shown in A. Note: 
the images are the most representative selected from the immunohistology performed on the three hADSCs patient 
derived cell lines. (C) The graph shows the quantification analysis of Col II fluorescence intensity normalized for 
the positive area (bars) and the percentage of the positive area for Col II (area fill). The calculations were 
performed on three different fields of view. One way Anova with Dunnett’s correction was applied to statistically 






In order to visualize the spatial distribution of cells and ECM deposition along the 
differentiation, we used Light Sheet microscopy, which allows, the reconstruction of a 3D 
image, while maintaining the physiological integrity of the bioscaffold, through optical sectioning 
of the sample. We labelled the bioscaffolds with Actin to detect cells and with Collagen type 
II to detect ECM generation. From our imaging analysis, we observed how hADSCs exerted 
the ability to condense in the GelMa/HAMa hydrogel scaffold during the chondrogenesis 
(Figure 7). Cells are evenly distributed along the entire depth of the printed scaffold right after 
the printing (Figure 7(A, C)), but condensed toward the superficial areas of the bioscaffolds 
during the chondrogenic differentiation (Figure 7(B, D)). In contrast, the condensation 
phenomenon was not visible without chondrogenic stimuli (Supp. figure 4). Collagen type II 
deposition is clearly visible at week 4 in the area where cells are condensed. The stem cell 
condensation is in fact required for the inception of the chondrogenic program during limb 




Figure 7. Neocartilage building and cells condensation during chondrogenesis. (A,B) Immunostaining 
analysis on 10 µm cryosections from Biopen biofabricated samples at Week 0 and Week 4 of chondrogenesis, 
performed using Texas Red-X Phalloidin (in red) to detect cell condensation. (C,D) Light sheet microscopy 
performed on the entire bioscaffolds (shown in grey, 1 mm height) at Week 0 and 4, after labelling with Texas 
Red-X Phalloidin and Collagen type II antibody. The stained Actin is shown in red in the superimposed panel 
with the bioscaffold (left column), and in rainbow colour code to show the depth and the localization of cells 
throughout the entire depth of the bioscaffold (middle column). The raibow color code represents a range of depth 
that goes from 0 mm (violet colour) to 1 mm (red colour). Collagen type II is shown in green (right column) to 







3.2.4. Collagen II fibrillary organization in GelMa/HAMa bioscaffolds  
Visualization of the 3D arrangement of the extracellular matrix (ECM) and living cells in native 
hydrated conditions is crucial to ensure the formation of a hyaline-like tissue [49]. In addition, 
it is important to understand if the accumulation of Collagen type II is combined with the 
organization of mature collagen fibrils that provides the strength and the function to the 
neotissue. 
Hence, the immunohistochemistry analysis was complemented with nonlinear microscopy, a 
non-invasive methodology that allows to simultaneously acquire second-harmonic generation 
(SHG) images of collagen and two-photon excited autofluorescence (TPE) images of living 
cells in label-free biofabricated scaffolds (Figure 8(A)).  
In the acellular scaffolds that were maintained in chondrogenic media for 8 weeks, TPE and 
SHG were not detectable, indicating that the composition of GelMa/HAMa did not interfere 
with the two signals’ generation (Figure 8(B)). In the chondrogenic induced bioscaffolds, we 
were able to detect TPE signals from cells embedded in the GelMa/HAMa and SHG derived 
image of collagen fibrils surrounding the cells (Figure 8(D)). In contrast, in absence of 
chondrogenic stimuli, only TPE signal was detectable (Figure 8 (C). The collagen-like fibrils 
detected by SHG are only attributable to the building of neocartilage from stem cells 
undergoing chondrogenesis. Importantly, given that the corresponding immunostaining 
performed on the same sections was able to detect only Collagen type II protein accumulation 
in the ECM, rather than Collagen type I or Collagen type X (Figure 6 and Supp. Figure 3), 





          
         
Figure 8. Neocartilage building and organization of collagen type II fibrils. (A) Schematic cartoon showing 
the non-linear microscopy whereby dual-photon excitation gives rise to two-photon excitation (TPE) and second 
harmonic generation (SHG). Under dual-photon excitation conditions, non-centrosymmetric structures (such as 
collagen molecules) absorb and release energy in a different way to subcellular proteins. The light emitted from 
the excited non-centrosymmetric structures return at double energy, but half the wavelength of the original 
excitation photons generating images of the fibrillary structures of collagen proteins. (B) Representative image of 
the acellular control scaffold. (C) Representative images of hADCSs laden in GelMa/HAMa after 8 weeks in 
control media. (D) Representative images of hADCSs laden in GelMa/HAMa after 8 weeks of chondrogenic 
differentiation. Note: Samples have been fixed and cryosectioned and directly imaged for non-linear microscopy 







3.2.6. Mechanical evaluation of GelMa/HAMa bioscaffolds during chondrogenesis 
In order to characterize the functional development of the in vitro generated tissue, we used 
unconfined compression testing (Figure 9) on the three hADSCs cell lines in triplicate for each 
indicated time point. The unconfined compressive modulus measured in non chondrogenic 
bioscaffolds was 57.28 kPa (+/-26.8) and 29.9 kPa (+/- 23.4) after 8 weeks of chondrogenesis 
without any significative difference between the groups (Figure 9(A)).  
Moreover, the bioscaffolds exerted a compressive modulus of 61.2 (+/- 36.5) at week 0 (data 
not shown). Overall, we measured that the bioscaffolds maintain consistent mechanical 
properties along the chondrogenic differentiation. However, by analysing the surface of our 
bioscaffolds at a microscale level by Atomic Force Microscopy indentation, we found that the 
Young’s modulus of five different localized area of three different samples was 660 kPa (+/- 
1119) after 8 weeks of chondrogenesis and only 191.7 kPa (+/- 140.7) in their relative non 
chondrogenic controls. The high variability of the chondrogenic samples reflects the 
accumulation of biological derived ECM, for which organization is based on collagen fibrils 
and cannot result in a flat homogeneous surface. The stiffness is on average 3.45 times higher 
than their control counterparts, which in contrast showed a much lower standard deviation 
(Figure 9(B)).  
Thus, the secreted matrix causes a gain in mechanical strength that cannot be detected by 
unconfined mechanical tests due to the non-homogeneous organization of the neocartilage 









        
                              
Figure 9. Mechanical properties evaluation. (A) The graph shows the unconfined compressive modulus of 
control and chondrogenic samples after 8 weeks. Error bars represents standard deviation between three biological 
replicates and significativity was calculated with unpaired t-test. (B) The graph  indicates Young’s modulus values 
obtained from analysing force curves using the Hertz indentation model of control and chondrogenic samples after 
8 weeks.  .Error bars represents standard deviation between three biological replicates and significativity was 
calculated with unpaired t-test. These analyses have been performed on three hADSCs, undergoing chondrogenic 
differentiation, derived from three different patients.   
 
4. Discussion 
The results of this study demonstrate that the Biopen can be used to produce human hyaline-
like cartilage in vitro by co-axial extrusion of adipose-derived stem cells (hADSCs) laden in 
GelMa/HAMa hydrogel.  
The necessity for the development of a handheld device is dictated by surgical needs: cartilage 
injuries have to be cleaned and debrided before any regenerative solution can be attempted 
surgically, therefore impeding the perfect matching of laboratory-produced bioscaffolds.  
In this study, we have used the handheld extrusion device (Biopen) in the same fashion as it 
would be used surgically, to simulate its clinical applicability.  
The ideal cell type to be used for cartilage regeneration is still a matter of debate. A number of 
cell sources have been investigated, the most common being mature articular chondrocytes, 
chondrocyte progenitors, and stem cells [50]. It is accepted that overall mesenchymal stem 
cells must possess a proven chondrogenic capacity, must not cause donor-site morbidity, and 
must be readily expandable in culture without losing their phenotype [51]. The number of stem 
cells-based clinical trials currently running worldwide and focused on cartilage repair is in fact 
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increasing [52]. Recently, a group of stem cells isolated from joint tissue, such as chondrogenic 
stem/progenitors from cartilage itself, synovial fluid, synovial membrane, and infrapatellar fat 
pad (IPFP) have gained great attention due to their increased chondrogenic capacity over the 
bone marrow and subcutaneous adipose-derived stem cells [53]. Indeed, the infrapatellar fat 
pad, has gained much attention as a source of  hADSCs with high chondrogenic capacity both 
in vitro and in tissue regenerative medicine approaches [53]. Human ADSCs also express 
CD44, which is the Hyaluronic Acid receptor involved in cell-cell and cell-matrix interactions, 
therefore playing an important role in the early stages of cartilage regeneration [54]. By 
expressing CD44, these cells are more prone to bind the hyaluronic acid residues present in the 
GelMa/HAMa bioink favouring the chondrogenic process. Therefore, for our study we have 
selected hADSCs harvested from the infrapatellar fat pad, as the source for human cartilage 
regeneration. Furthermore, we have shown that stem cells isolated from the IPFP of patients 
affected by mild/severe OA, retain their chondrogenic potential, thus establishing the milestone 
for the treatment of cartilage injuries via using a personalized medicine approach using 
autologous stem cells [55]. Despite the heterogeneity of the clinical status of the patients, the 
data obtained showed consistent results among the different stem cells lines tested, defining 
our stem cells source, the human fat pad, as a good candidate for the clinical application.  
In our previous study we have demonstrated that a core/shell distribution of our scaffold 
reliably protects the survival and proliferation capacity of hADSCs [31].  
The co-axial extrusion approach have been proposed by other groups, they aimed to use a 
viscous sacrificial shell to allow the deposition of a liquid cellular compartment that cannot 
otherwise hold a predetermined shape, thus performing the hardening procedure before the 
removal of the sacrificial compartment [56] [57] [58].  
The advantage of our technology relies instead on a different application of core/shell 
geometry. The segregation of the photocrosslinkable shell away from the cellular compartment, 
which is not photocrosslinked, is designed to protect the cells during the biofabrication process 
without compromising structural or cellular integrity. Our co-axial strategy geometrically 
compartmentalizes a solid phase that facilitates appropriate stiffness requirements, and a 
viscous liquid phase that preserves cell viability by separating cells from PIs and the cytotoxic 
chemical by-products coming from the crosslinking reaction going on within the solid phase. 
As shown in our previous study [31], the segregation of the core and shell compartments is 
well defined right after the biofabrication process. 
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Thus, we produced GelMa/HAMa bioscaffolds by means of Biopen mediated co-axial 
extrusion to assess whether the fabricated environment is permissive for neocartilage 
generation in vitro.   
Expression of Hyaline-like cartilage components was assessed first by RT-qPCR. SOX9, the 
master regulator of chondrogenesis, is expressed at transcriptional level but not at translational 
level before the chondrogenic induction, reflecting the chondrogenic potential of the stem cells 
source. However, SOX9 transcript accumulates over time under chondrogenic stimuli, 
reaching an expression plateau at week 4, with a consequent accumulation of the translated 
protein that continue to accumulate until week 8. This apparent discrepancy can be ascribed to 
the several post translational modification that regulates the stability of SOX9 in the cells. In 
fact, SOX9 is subjected to ubiquitin mediated proteasomal degradation effected by the E3 
ubiquitin ligase FBW7 [59] [60] and by the E6 ubiquitin ligase UBE3A [61]. Moreover, the 
activation of TGFb pathway leads to the stabilization of SOX9 by the phosphorylation of Serine 
211 [62]. Thus, despite the transcriptional expression of SOX9 reaches a plateau, post 
translational modifications, triggered by chondrogenic stimuli, can positively affect the 
stability of the protein, leading to the activation of its transcriptional targets. In fact, COL2A1 
and ACAN are not expressed at the start of the chondrogenesis, but are detectable at week 4 
showing a 300 and 20 fold increase respectively at week 8. COL1A2, an accepted marker of 
fibrocartilage formation, is express in hADSCs populations and shows an increase of only 10 
times over the entire length of chondrogenic stimulation. This is consistent with other studies 
that analyse the chondrogenic potential of 3D bioprinted hADSCs [42]. The production and 
accumulation of ECM containing Collagen type II, Proteoglycan and Glycosaminoglycans was 
demonstrated in a time-related manner both histologically and immunophenotypically. 
hADSCs secreted a significant amount of Collagen type II and Proteoglycan around the cell 
bodies and in the scaffold matrix. In contrast, no significant extracellular accumulation of 
Collagen type I was observed over time in the analysed bioscaffold.  It has been shown that the 
ratio between Collagen type II and Collagen type I is the discriminant to define hyaline-like 
ECM [63]. After chondrogenic stimulation, the mentioned ratio is considerably higher in the 
GelMa/HAMa bioscaffolds both at transcriptional and translational level. Our settings are 
consistent with other studies showing Col II accumulation after 28 days of differentiation and 
performed using GelMa based bioinks and animal derived stem cells [64]. Moreover, the 
production of hyaline-like matrix we observed  is highly efficient with respect to that generated 
from adult chondrocytes loaded in GelMa ink [65], underlining once again the superiority of 
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hADSCs as a source of cells for the production of ECM in scaffold-based cartilage regeneration 
applications. 
To further characterise our bioscaffolds, we have shown collagen fibrils formation and 
distribution using non-linear two photon microscopy and second harmonic generation 
(SHG)[66] [67]. This technique can detect only mature fibrillary collagen.  Our results 
showed that Collagen type I and X are expressed at the intracellular level. In contrast, 
Collagen II are secreted and accumulated in an organized extracellular matrix after 8 weeks 
of chondrogenesis. Thus, is very likely that mature Collagen II is the major contributor of the 
SHG signal.  
The pattern of matrix deposition in bioscaffolds resembles the early stages formation of the 
growth plate with an accumulation of collagen type II in the surface of the developing tissue. 
It is in fact well established that cartilage formation begins with mesenchymal condensation 
leading to chondrogenic differentiation of mesenchymal cells. Then, a dense matrix is 
produced, serving as the cartilage anlage, a template for the subsequent generation of both the 
articular cartilage and the subchondral bone [48][49]. The formation of physiologic tissue by 
progenitor cells ultimately required lessons taken from native tissue morphogenesis. Self-
assembly has been proposed as an in vitro method for recapitulating mesenchymal 
condensation that precedes chondrogenesis [68]. However current tissue-engineered scaffolds 
for chondrogenesis pay little attention to this phenomenon or focused more on the modification 
of the bioink by adding growth factors or decellularized ECM components to help the cellular 
condensation [69], while others use cells pre-clustered into pellets prior to 3D manufacturing 
to mimic the mesenchymal condensation [70]. With our setting instead, we demonstrated that 
hADSCs are able to condense under in vitro chondrogenic stimulation and successfully 
produce hyaline-like bioscaffolds. Moreover, the peripheral distribution of matrix formation is 
promising in the view of the entire osteochondral tissue regeneration. In the future, the 
possibility to deliver a gradient of osteogenic and chondrogenic growth factors within the 
hydrogel could promote the selective tissue differentiation allowing the formation of bone and 
cartilage simulating the entire osteochondral unit [71]. Importantly, our culture technique was 
performed in a static fashion, therefore not stimulating the orientation of the collagen fibres in 
a way to recapitulate hyaline-like cartilage structures. To better simulate the physiological 
environment within the joint, the use of a dynamic culture systems will be necessary to improve 
the orientation of the collagen fibres, as shown in previous studies [72]. Mechanical resistance 
to stress is undoubtedly a key element in cartilage tissue engineering: just like native articular 
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cartilage, the regenerated tissue needs to be able to sustain the loads applied on the joint and 
distribute them evenly in the underlying subchondral bone. There is currently no consensus on 
the expected results from mechanical testing following cartilage regeneration in hydrogels. 
While several studies have shown that after 4 or 8 weeks in chondrogenic culture media, 3D 
printed samples show increase in the compression modulus [73], other studies show decrease 
or stagnation of mechanical properties with time in compression [74], and in tension [75]. In 
our study, by unconfined compression tests, we found no statistically significant difference of 
the bulk mechanical properties between chondrogenic bioscaffolds and their control 
counterparts. Importantly, several studies aiming at cartilage matrix growth in hydrogels 
demonstrated a compressive modulus after 8 weeks reaching about 50kPa [73][74] [76], which 
is the constant modulus of our hydrogel. While this compressive modulus is achieved during 
the chondrogenic process in vitro, with our approach it is possible to obtain a comparable 
stiffness right after the biofabrication process. The mechanical behaviour of the bioscaffolds is 
determined by the interplay between intrinsic degradation of the biomaterial components, cell 
mediated degradation and ECM deposition [77]. However, by performing atomic force 
microscopy indentation, we have demonstrated that in correspondence of accumulated ECM 
there is a marked increase in Young’s modulus at 8 weeks of chondrogenesis, compared to 
undifferentiated samples. This analysis highlights the importance of considering spatial 
variations in constructs. These results reflect the fact that ECM accumulation lead to a gain in 
mechanical resistance in localized regions that correspond to the area of where cell 
condensation happens. In our next studies, the phenotype and migration of the cells, matrix 
deposition, proteolytic activity and construct degradation rate will be evaluated and correlated 
with de novo cartilage formation to better understand the interaction between hADSCs and 
crosslinked GelMa/HAMa hydrogel [78].  
5. Conclusion 
The clinical application of hydrogel based bioscaffolds has the potential to effect the 
regeneration of articular cartilage. In this study, we have demonstrated that human Infrapatellar 
Fat Pad Adipose-derived Stem Cells can produce hyaline-like cartilage in GelMa/HAMa 
bioscaffolds. The in vitro biofabrication of human neocartilage via a handheld extrusion device 
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